IQVIA Holdings Inc. (NYSE:IQV) Stock Holdings Raised by Oak Harbor Wealth Partners LLC

Oak Harbor Wealth Partners LLC lifted its stake in shares of IQVIA Holdings Inc. (NYSE:IQV) by 9.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,332 shares of the medical research company’s stock after purchasing an additional 282 shares during the period. Oak Harbor Wealth Partners LLC’s holdings in IQVIA were worth $790,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the company. Tokio Marine Asset Management Co. Ltd. raised its stake in IQVIA by 2.3% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 5,268 shares of the medical research company’s stock valued at $1,248,000 after buying an additional 117 shares in the last quarter. Huntington National Bank raised its position in shares of IQVIA by 7.4% during the 3rd quarter. Huntington National Bank now owns 809 shares of the medical research company’s stock valued at $192,000 after acquiring an additional 56 shares in the last quarter. Oppenheimer Asset Management Inc. lifted its stake in IQVIA by 17.3% during the third quarter. Oppenheimer Asset Management Inc. now owns 13,360 shares of the medical research company’s stock worth $3,166,000 after purchasing an additional 1,974 shares during the last quarter. Cumberland Partners Ltd boosted its holdings in IQVIA by 4.1% in the third quarter. Cumberland Partners Ltd now owns 1,660 shares of the medical research company’s stock worth $393,000 after purchasing an additional 65 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. increased its stake in IQVIA by 3.9% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,023,264 shares of the medical research company’s stock valued at $242,483,000 after purchasing an additional 38,307 shares during the last quarter. 89.62% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the stock. TD Cowen reduced their price target on shares of IQVIA from $270.00 to $255.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Argus upgraded IQVIA to a “strong-buy” rating in a research note on Wednesday, July 31st. Royal Bank of Canada reiterated an “outperform” rating and set a $270.00 price target on shares of IQVIA in a research report on Friday, November 1st. Jefferies Financial Group lowered IQVIA from a “buy” rating to a “hold” rating and reduced their price objective for the company from $266.00 to $242.00 in a research report on Wednesday, July 24th. Finally, JPMorgan Chase & Co. reduced their price objective on IQVIA from $279.00 to $240.00 and set an “overweight” rating for the company in a research report on Tuesday, November 5th. Five investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $259.13.

Insider Activity

In other news, insider Eric Sherbet sold 1,300 shares of the stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total transaction of $320,229.00. Following the completion of the sale, the insider now owns 19,536 shares in the company, valued at approximately $4,812,302.88. This represents a 6.24 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.60% of the company’s stock.

IQVIA Stock Down 4.1 %

NYSE IQV opened at $202.94 on Friday. The company has a debt-to-equity ratio of 1.76, a current ratio of 0.81 and a quick ratio of 0.81. The company’s 50 day simple moving average is $228.86 and its 200 day simple moving average is $228.77. IQVIA Holdings Inc. has a 12 month low of $200.20 and a 12 month high of $261.73. The company has a market capitalization of $36.83 billion, a P/E ratio of 26.63, a PEG ratio of 2.17 and a beta of 1.51.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.